Catalyst Wire Dossier Catalyst Wire Dossier

Sodium Hyaluronate 2.0%

sodium hyaluronate · TRB Chemedica
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sodium Hyaluronate 2.0%, covering 2012-11-21 to 2012-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of Evaluating the Duration of Efficacy of One Intra Articular Injection of Sodium Hyaluronate 2.0% in Patients With Painful Osteoarthritis of the Knee [Phase 2]

See pricing